Brightsurf Science News & Current Events

September 28, 2014
More children admitted to intensive care but with lower staffing ratios
More children than ever are being admitted to intensive care units in England and Wales but there are fewer staff per bed available to cope with the increase, according to a new report published jointly by the University of Leeds and University of Leicester.

Many patients lack information about the use of targeted therapies, oncologists say
More than three quarters of oncology specialists in Europe, South America and Asia believe their patients are not always well enough informed about the treatment options available to them, survey results have revealed at the ESMO 2014 Congress in Madrid, Spain.

Under-representation of women in oncology leadership positions
A growing number of oncologists in Greece are female, but women continue to be under-represented in leadership positions, according to a survey reported at the ESMO 2014 Congress.

Pertuzumab adds 16 months survival benefit to trastuzumab and chemo treatment for HER2-positive breast cancer
Patients with HER2-positive breast cancer that has spread to other parts of their body live around 16 months longer if treated with a combination of pertuzumab, trastuzumab and chemotherapy compared to those treated with trastuzumab and chemotherapy alone, updated results from the CLEOPATRA study reveal.

Human genome was shaped by an evolutionary arms race with itself
New findings by scientists at the University of California, Santa Cruz, suggest that an evolutionary arms race between rival elements within the genomes of primates drove the evolution of complex regulatory networks that orchestrate the activity of genes in every cell of our bodies.

Adding cediranib to chemo improves progression-free survival for meta or recurrent cervical cancer
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid.

Smart, eco-friendly new battery to solve problems
Present-day lithium batteries are efficient but involve a range of resource and environmental problems.

Researchers identify early sign of pancreatic cancer
Scientists at Dana-Farber Cancer Institute, the Massachusetts Institute of Technology, and other institutions have discovered a sign of the early development of pancreatic cancer -- an upsurge in certain amino acids that occurs before the disease is diagnosed and symptoms appear.

IMPRESS trial data on continuing tyrosine kinase inhibitor therapy after resistance development in lung cancer reported
Patients whose lung cancer has developed resistance to the drug gefitinib experience no statistically significant improvement in progression-free survival from continued treatment with the drug in addition to chemotherapy, a phase III trial presented at the ESMO 2014 Congress has shown.

Is expressive suppression effective in reducing negative emotion?
It is a prevailing conclusion in European-American population that expressive suppression is unable to effectively reduce negative emotion and physiological arousal.

Using the brain to forecast decisions
In a research published on Sept. 28, 2014, in the journal Nature Neuroscience, scientists show that neural recordings can be used to forecast when spontaneous decisions will take place.

Revolutionary hamstring tester will keep more players on the field
Elite sporting stars can assess and reduce their risk of a hamstring injury thanks to a breakthrough made by researchers from the Queensland University of Technology, in Brisbane, Australia.

Protein that causes frontotemporal dementia also implicated in Alzheimer's disease
Low levels of the naturally occurring protein progranulin exacerbate cellular and cognitive dysfunction, while raising levels can prevent abnormalities in an Alzheimer's model.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.